Reshaping Hypertension™ with the MobiusHD® System
Now enrolling in the CALM-2 clinical study for patients with poorly controlled hypertension
Hypertension impacts 1 billion people worldwide and the clinical consequences are devastating
AMPLIFY
Reshaping of carotid sinus amplifies baroreceptor signaling to the brain
REDUCE
Significant blood pressure reduction demonstrated in multiple clinical studies.
LONG LASTING
Durable safety and efficacy at two-years
NON-SURGICAL
Minimally invasive access using endovascular techniques
Clinical Trials
CALM-FIM was a prospective, first-in-human, open-label study done at six sites in Europe. The MobiusHD system was studied in patients with an office systolic blood pressure ≥160 mmHg despite taking at least three antihypertensive agents, including a diuretic.
Results showed a significant decrease in mean ambulatory blood pressure in 73% of patients at 24 hours and blood pressure reduction of 21/12 mmHg at six months, as compared to baseline4.
Contact Us
Want to learn more about Vascular Dynamics or have a question about our approach? Use the contact form and let’s start a conversation.